AMA CPT® Assistant - 2006 Issue 6 (June)
Medicare Reporting Update, Part II: 2006 Oncology Demonstration Project, Anti-emetic Drugs, Procedure Devices, AQ Modifier (June 2006)
June 2006 pages 11-15 Medicare Reporting Update, Part II: 2006 Oncology Demonstration Project, Anti-emetic Drugs, Procedure Devices, AQ Modifier Medicare Reporting Update, Part I This month, CPT Assistant features Part II of the Medicare reporting changes effective for 2006. This article is presented to assist physicians, nonphysician practitioners, and hospitals discern the appropriate use of both CPT and Healthcare Common Procedure Coding System (HCPCS) codes and modifiers when reporting to Medicare. Oncology Demonstration Project The Centers for Medicare and Medicaid Services (CMS) Change Request 4219 announces the implementation of the Medicare oncology demonstration project for hematologists and oncologists who...
Subscribe or sign in to view the full article.
Article Overview
This CPT Assistant article summarizes several Medicare reporting updates for 2006. It is aimed at physicians, nonphysician practitioners, and hospitals that submit claims involving oncology demonstration reporting, anti-emetic drug coverage issues, outpatient procedure device reporting, and geographic bonus-related modifier use. The article describes the affected CMS change requests, the general reporting categories involved, and the administrative context for claims processing and denial handling.
Why This Topic Matters
The article helps billing and coding professionals understand which Medicare reporting topics changed in 2006 and where CMS guidance affected claim submission, claim edits, and modifier use. It is relevant to organizations that bill oncology services, hospital outpatient procedures, or Medicare claims involving special geographic payment rules.
Article Sections
-
Oncology Demonstration Project
Overview of the 2006 Medicare oncology demonstration project and its purpose. Covers the transition from the prior chemotherapy demonstration and the general reporting framework tied to oncology E/M services.
-
Three Reporting Categories
Summarizes the three broad categories used in the oncology demonstration reporting structure. Explains the types of information CMS intended to collect through the project.
-
Diagnostic Categories
Lists the cancer diagnosis groupings associated with participation in the oncology demonstration. Identifies the specialties and established-patient E/M services referenced for the program.
-
Qualifications
Describes the general reporting requirements tied to qualifying for the demonstration payment. Addresses how the reporting categories relate to claim submission.
-
Participation
Explains who may participate in the oncology demonstration and the claim-processing consequences for nonqualifying submissions. Includes the specialties and Medicare denial handling discussed in the article.
-
E/M Service: Modifier 25 Usage
Discusses reporting considerations when an evaluation and management service occurs on the same day as another service. Focuses on the documentation and modifier-related guidance CMS provided.
-
Specific Reporting Instruction
Covers claim submission rules for the demonstration reporting categories and the associated Medicare rejection or denial handling. Also notes place-of-service requirements and references to CMS carrier instructions.
-
Medicare Claims Processing: Anti-Emetic Drugs
Reviews Medicare denial messaging for certain anti-emetic drug claims. Identifies the CMS and Medicare notice references used for processing guidance.
-
Hospital Outpatient Prospective Payment System Device Reporting
Summarizes OPPS device-reporting updates, including CMS edits and the relationship between procedure claims and device reporting. Notes the shift in reporting expectations over time and the CMS resources referenced.
-
Required Hospital Reporting
Describes the hospital reporting expectations for procedures that require devices under OPPS. Discusses claim editing and the conditions under which the edits apply.
-
Coding Tip
Provides a brief coding note about the term HCPCS as used in the article. Clarifies the general terminology referenced by CMS.
-
CPT Modifier Usage
Reviews modifier-related guidance connected to device edits for outpatient procedures. Includes the CMS discussion of when certain modifiers affect edit application.
-
Use of Modifier AQ
Explains the CMS guidance changes related to modifier AQ and geographic bonus payment information. Covers the administrative background and where CMS directed readers for updated instructions.
-
Background
Provides the policy background for geographic bonus payments and self-designation guidance. References the statutory and CMS context behind the modifier AQ update.
What You Will Learn
- How CMS organized the 2006 oncology demonstration reporting framework
- What general categories of information were tied to the oncology demonstration
- Which kinds of Medicare claims and settings were affected by the reporting update
- How outpatient hospital device reporting was addressed in the CMS guidance
- What administrative topics were associated with modifier AQ and geographic bonus areas
Who Should Read This
- Physicians
- Hematologists and oncologists
- Hospitals
- Nonphysician practitioners
- Medical coders
- Billing staff
- Revenue cycle professionals
Codes Discussed
Code Ranges Discussed
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com
